Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane

Microscopy Research and Technique

Volumn 55, Issue 2, 2001, Pages 100-107

  Papoutsi, Maria ^a   Sleeman, Jonathan P ^b   Wilting, Jörg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Angiogenesis; Lymphangiogenesis; Smooth muscle actin; Tumor; VEGF C; VEGFR 3

Indexed keywords

BLOOD; BLOOD VESSELS; CELL ENGINEERING; CYTOLOGY; ENDOTHELIAL CELLS; MUSCLE; PROTEINS; RATS;

ANGIOGENESIS; CHORIO-ALLANTOIC MEMBRANES; ENDOTHELIAL-CELLS; GROWTH FACTOR; LYMPHANGIOGENESIS; SMOOTH MUSCLE ACTINS; TUMOUR CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; VEGF-C;

TUMORS;

ALPHA ACTIN; ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL INTERACTION; CHICKEN; CHORIOALLANTOIS; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; IN SITU HYBRIDIZATION; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC SYSTEM; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUAIL; RAT; TUMOR CELL; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALIA; AVES; PHASIANIDAE;

EID: 0035887301     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1161     Document Type: Article

References (60)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. 1998. Vascular endothelial growth factor-D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (FH4). Proc Natl Acad Sci USA 95:548-553.
2. Armstrong PB, Quigley JP, Sidebottom E. 1982. Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines. Cancer Res 42:1826-1837.
3. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571.
4. Budge A. 1887. Untersuchungen über die Entwicklung des Lymphsystems beim Hühnerembryo. Arch Anat Entwickl-Gesch 59-89.
5. Bunone G, Vigneri P, Mariani L, Collini P, Pilotti S, Pierotti MA, Bongarzone I. 1999. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 155:1967-1976.
6. Campbell JG. 1949. The cultivation of tumors in the fertile egg, with special reference to associated ectodermal lesions of the chorioallantoic membrane. Br J Cancer 3:72-88.
7. Cann SA, van Netten JP, Ashby TL, Ashwood-Smith MJ, van der Westhuizen NG. 1995. Role of lymphangiogenesis in neovascularization. Lancet 346:903.
8. Dagg CP, Karnofsky DA, Roddy J. 1956. Growth of transplantable human tumors in the chick embryo and hatched chick. Cancer Res 16:589-594.
9. Eichmann A, Marcelle C, Bréant C, Le Douarin NM. 1996. Molecular cloning of Quek1 and 2, two avian vascular endothelial growth factor (VEGF) receptor-like molecules. Gene 174:3-8.
10. Folkman J. 1974. Tumor angiogenesis factors. Cancer Res 34:2109-2113.
11. Folkman J. 1996. Angiogenesis and tumor growth. N Engl J Med 334:921.
12. Gale NW, Yancopoulos GD. 1999. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13:1055-1066.
13. Herrlinger U, Buchholz R, Jachimczak P, Schabet M. 1996. Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interleukin-2. J Neurooncol 27:193-203.
14. Hofmann M, Fieber C, Assmann V, Gottlicher M, Sleeman J, Plug R, Howells N, von Stein O, Ponta H, Herrlich P. 1998. Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein. J Cell Sci 111:1673-1684.
15. Jain RK. 1988. Determinants of tumor blood flow: a review. Cancer Res 48:2641-2658.
16. Jeltsch MM, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425.
17. Joukov V, Sorsa T, Kumar V, Letsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K. 1997. Proteolytic processing regulates receptor specifity and activity of VEGF-C. EMBO J 16: 3898-3911.
18. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566-3570.
19. Kaufman N, Kinney TJ, Mason EJ, Prieto LC. 1956. Maintenance of human neoplasm on the chick chorioallantoic membrane. Am J Pathol 32:271-285.
20. Kim J, Yu W, Kovalski K, Ossowski L. 1998. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semi-quantitative PCR-based assay. Cell 94:353-362.
21. Lauria R, Perrone F, Carlomagno C, De Laurentiis M, Pettinato G, Panico L, Petrelle G, Bianco R, De Placido S. 1995. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 15:1772-1778.
22. Lee AKC, DeLellis RA, Silverman ML, Heatley GJ, Wolfe HJ. 1990. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 8:1457-1465.
23. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. 2000. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324-4327.
24. Lindahl P, Johansson BR, Leven P, Betsholtz C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-245.
25. Lubach D, Berens von Rautenfeld D, Kaiser HE. 1992. The possible role of the initial lymph vessels of the skin during metastasis of malignant tumors. In vivo 6:443-450.
26. Macchiarini P, Dulmet E, De Montpreville V. 1995. Prognostic significance of peri-tumoural blood and lymphatic vessel invasion by tumour cells in T4 non-small cell lung cancer following induction therapy. Surg Oncol 4:91-99.
27. Maehara Y, Oshiro T, Baba H, Ohno S, Kohnoe S, Sugimachi K. 1995. Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery 117:380-385.
28. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper M. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672-682.
29. Matzku S, Wenzel A, Liu S, Zöller M. 1989. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res 49:1294-1299.
30. Mostafa LK, Jones DB, Wright DH. 1980. Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: studies on the chorioallantoic membrane (CAM) of the chick embryo. J Pathol 132:191-205.
31. Murphy JB. 1913. Transplantability of tissues to the embryo of foreign species. Its bearing on questions of tissue specifity and tumor immunity. J Exp Med 17:482-493.
32. Murphy JB, Rous P. 1912. The behavior of chicken sarcoma implanted in the developing embryo. J Exp Med 15:119-132.
33. Nestl A, Von Stein O, Zatloukal K, Thies W-G, Herrlich P, Hofmann M, Sleeman JP. 2001. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 61:1569-1577.
34. Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy JEG, Weich HA, Christ B, Alitalo K, Wilting J. 1997. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188:96-109.
35. Ossowski L, Reich E. 1980. Experimental model for quantitative study of metastasis. Cancer Res 40:2300-2309.
36. Papoutsi M, Schächtele C, Marmé D, Christ B, Wilting J. 1999. Interaction of VEGF-C-expressing melanoma cells with lymphatics of the avian chorio-allantoic membrane. Ann Anat Suppl 181:224.
37. Papoutsi M, Siemeister G, Weindel K, Tomarev S, Kurz H, Schächtele C, Martiny-Baron G, Christ B, Marmé D, Wilting J. 2000a. Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol 114:373-385.
38. Papoutsi M, Kurz H, Schächtele C, Marmé D, Christ B, Pröls F, Wilting J. 2000b. Induction of the blood-brain barrier marker neurothelin/HT7 in endothelial cells by a variety of tumors in chick embryos. Histochem Cell Biol 113:105-113.
39. Pardanaud L, Altmann C, Kitos P, Dieterlen-Lièvre F, Buck CA. 1987. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. Development 100: 339-349.
40. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE. 1995. Incidence and prognostic significance of vascular and neural invasion in squamous cell carcinoma of the esophagus Int J Cancer 61:333-336.
41. Scher CD, Haudenschild C, Klagsbrun M. 1976. The chick chorioallantoic membrane as a model system for the study of tissue invasion by viral transformed cells. Cell 8:373-382.
42. Schrek R, Avery RC. 1937. Histological observations on transplantable rat and embryos, with special reference to the Walker rat tumor 256. Am J Pathol 13:45-51.
43. Serra JA. 1946. Histochemical tests for protein and aminoacids: the characterization of basic proteins. Stain Technol 21:5-18.
44. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198.
45. Sleeman JP. 2000. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 157:55-81.
46. Sleeman JP, Arming S, Moll J, Hekele A, Rudy W, Sherman L, Kreil G, Ponta H, Herrlich P. 1996. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res 56:3134-3141.
47. Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, Roufail S, Simpson RJ, Moritz R, Karpanen T, Alitalo K, Achen MG. 1999. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274:32127-32136.
48. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa Shi S, Kubo H, Achen MG. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191.
49. Stevenson NN. 1918. Growth of tumors in the chick embryo. J Cancer Res 3:63-74.
50. Tanigawa N, Kanazawa T, Satomura K, Hikasa Y, Hashida M, Muranishi S, Sezaki H. 1981. Experimental study on lymphatic vascular changes in the development of cancer. Lymphology 4:149-154.
51. Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K, Koji T. 1999. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80:309-313.
52. Vaupel PW, Frinak S, Bicher HI. 1981. Heterogenous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res 41:2088-2013.
53. Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K. 2001. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20:1223-1231.
54. Weber WT, Mausner R. 1977. Migration patterns of avian embryonic bone marrow cells and their differentiation to functional T and B cells. In: Benedict AA, editor. Avian immunology. New York: Plenum Publishing, p 47-59.
55. Weidner N. 1995. Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol 147:9-19.
56. Wilting J, Brand-Saberi B, Huang R, Zhi Q, Königes G, Ordahl CP, Christ B. 1995. Angiogenic potential of the avian somite. Dev Dyn 202:165-171.
57. 121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of the chorioallantoic membrane. Dev Biol 176:76-85.
58. Wilting J, Papoutsi M, Siemeister G, Weindel K, Schächtele C, Martiny-Baron G, Christ B, Marmé D. 1999. Induction of lymphangiogenesis and invasion of lymphatics by melanoma cells are two separate mechanisms. Ann Anat Suppl 181:35.
59. Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K, Sasaki T. 1999. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5:1823-1829.
60. Zeidman I, Copeland B, Warren S. 1955. Experimental studies on the spread of cancer in the lymphatic system. II. Absence of the lymphatic supply in carcinoma. Cancer 8:123-127.